Published: December 2024 | Last updated: May 2026
Gonorrhea in women is the kind of infection you can carry for months without knowing. About half of women who catch it have no symptoms at all, and the half who do tend to notice changes that are easy to blame on something else, like a yeast infection or a heavier period. That gap between infection and recognition is the entire reason untreated gonorrhea is one of the two leading bacterial causes of pelvic inflammatory disease (PID), alongside chlamydia, and a major contributor to fallopian-tube damage and infertility in women under 30.
This article walks through what happens biologically when gonorrhea is left untreated, when PID typically develops, how the damage to fallopian tubes turns into long-term fertility problems, and what testing options actually catch the infection before it spreads. We also flag where at-home tests fit and where they do not, and what to do if you are already worried about an exposure.
What untreated gonorrhea actually does in the body
Gonorrhea is a bacterial infection caused by Neisseria gonorrhoeae. In women, the bacteria most often colonize the cervix first, which is why early infections frequently produce no obvious symptoms. The cervix is not particularly nerve-rich, and inflammation there rarely causes pain you would notice during everyday activity.
Left untreated, the infection does not stay at the cervix. N. gonorrhoeae attaches to and infects columnar epithelial cells, which line the entire upper female reproductive tract. From the cervix, the bacteria can ascend through the uterus and into the fallopian tubes, then into the pelvic cavity itself. This ascending route is what turns a localized infection into pelvic inflammatory disease.
According to the CDC's overview of gonorrhea, untreated infection can also spread to the blood or joints in rare cases, a condition clinicians call disseminated gonococcal infection. The much more common consequence, however, is the local spread upward through the reproductive tract.
How fast that ascent happens depends on several factors. The longer the infection goes untreated, the more time bacteria have to move upward. Menstrual cycles can speed the process because menstrual blood acts as a transport route. Co-infection with chlamydia is common and tends to accelerate progression, partly because chlamydia thrives in the same tissues and amplifies local inflammation.
In a small minority of untreated cases, the bacteria enter the bloodstream and cause disseminated gonococcal infection. The hallmark signs are fever, joint pain (often in the wrists, ankles, or knees), and small red or pus-filled skin lesions. This is a medical emergency that requires IV antibiotics, but it is not the typical course of untreated gonorrhea. Far more often, the infection stays local and ascends through the reproductive tract.
How a cervical infection becomes pelvic inflammatory disease
The transition from a localized cervical infection to PID usually takes weeks, not days. The exact timeline varies by individual, but the pattern described by the CDC's PID page is gradual: bacteria first establish in the cervix, then move upward into the endometrium (the lining of the uterus), and then into one or both fallopian tubes.
Once bacteria reach the fallopian tubes, the body mounts an aggressive inflammatory response. The tubes themselves are very narrow, with an interior diameter of only about 1 millimeter at their narrowest point. Swelling and pus production from infection can plug them entirely. Even after the infection is treated, scar tissue formed during the inflammatory phase can remain, narrowing or blocking the tube permanently.
Tubal damage takes one of several forms, each with a different implication for fertility:
- Partial scarring. The tube remains open but the inner lining loses some of its hair-like cilia. Cilia normally sweep a fertilized egg toward the uterus, so partial scarring raises the risk of ectopic pregnancy.
- Complete blockage on one side. The unaffected tube can still carry eggs from the ovary on that side. Fertility is reduced but not eliminated.
- Bilateral blockage. Both tubes are scarred shut. Natural conception is no longer possible without surgical repair or IVF.
The PID episode itself can be relatively mild or even silent. "Silent PID" is the term clinicians use for cases where a woman never had a clear flare-up but is later found to have tubal scarring during a fertility workup. This is why screening matters so much: by the time fertility problems are obvious, the damage that caused them has often already happened.
How quickly can untreated gonorrhea cause PID and fertility damage?
PID can develop within weeks of an untreated gonorrhea infection, although many cases progress silently over months. The CDC reports that about 1 in 8 women with a history of PID later have difficulty getting pregnant, and each repeat PID episode further raises that risk. Testing within a few weeks of any possible exposure is the most effective way to interrupt this timeline.
The warning signs of PID worth taking seriously
PID symptoms can range from severe to almost imperceptible, which is part of why it goes undiagnosed in a large share of cases. The symptoms below, especially in combination, are the ones that should prompt prompt medical assessment:
- Lower abdominal or pelvic pain. Often dull and constant rather than sharp. May worsen with movement or during sex.
- Pain during or after sex (dyspareunia). Especially deep-pelvic pain rather than discomfort at entry.
- Bleeding or spotting between periods. Particularly after intercourse.
- Heavier or more painful periods than usual.
- Vaginal discharge with an unusual color or odor. Yellow-green or grey, fishy or strong-smelling.
- Burning or pain when urinating.
- Fever or chills. A sign the infection has progressed and is causing systemic inflammation. This warrants urgent care.
Fever plus pelvic pain together is a red-flag combination. The NHS guidance on PID says to ask for an urgent GP appointment or call NHS 111 if you think you have PID symptoms, and to call 999 or go straight to A&E if the pain is severe, accompanied by heavy bleeding, a high fever, severe nausea, or shoulder pain. Untreated, a tubo-ovarian abscess (a pocket of pus around the tube and ovary) can develop and become a surgical emergency.
If you have lower abdominal pain plus a fever above 38°C (100.4°F), heavy bleeding, severe pain that wakes you up at night, or pain so intense you cannot stand upright, see a clinician the same day. These can be signs of advanced PID or a tubo-ovarian abscess, which can require IV antibiotics or surgery. An at-home swab is not the right tool for this scenario.
How PID damages fertility, in concrete numbers
The connection between PID and infertility is well established. The CDC's PID page states that about 1 in 8 women with a history of PID experience difficulties getting pregnant, and the risk grows with each subsequent episode because scar tissue accumulates with repeat inflammation.
PID damages fertility through several overlapping mechanisms:
- Tubal blockage. Scar tissue narrows or completely seals the fallopian tubes, preventing eggs and sperm from meeting.
- Cilial damage. The tiny hair-like structures that move eggs toward the uterus are destroyed or paralyzed by inflammation. Even an open tube can fail at its job.
- Pelvic adhesions. Inflammation can cause bands of scar tissue to form between organs, distorting the position of the ovary relative to the tube and preventing eggs from being captured at ovulation.
The table below summarizes how these mechanisms compound across repeated PID episodes. The figures are approximate ranges consistent with long-running public-health observations.
| Number of PID episodes | Approximate risk of fallopian-tube infertility | Risk of ectopic pregnancy |
|---|---|---|
| 1 episode | About 1 in 8 women | Elevated compared to women with no PID history |
| 2 episodes | Roughly 1 in 4 to 1 in 3 women | Higher than after a single episode |
| 3 or more episodes | Around 1 in 2 women | Continues to climb with each episode |
What untreated gonorrhea means during pregnancy
If gonorrhea is acquired or remains untreated during pregnancy, the risks shift. The infection can be passed to a newborn during vaginal delivery and cause neonatal conjunctivitis, which can damage eyesight without rapid treatment. Maternal complications include preterm labor, premature rupture of membranes, and low birth weight.
Ectopic pregnancy is the other major concern. When fallopian tubes have been scarred by prior PID, a fertilized egg can implant inside the tube instead of the uterus. Ectopic pregnancies are not viable and, if not caught early, can rupture the tube and cause life-threatening internal bleeding. The WHO gonorrhoea fact sheet lists ectopic pregnancy among the complications of untreated infection alongside PID and infertility.
If you are pregnant and think you may have been exposed to gonorrhea, do not wait for an at-home test result. Visit a clinic the same week. Treatment in pregnancy involves a specific antibiotic regimen and partner notification, both of which are time-sensitive.
At-home rapid tests are designed for adult non-pregnant screening. In pregnancy, the right path is a clinician-administered NAAT plus same-week follow-up if the result is positive, because the antibiotic choice and dose are adjusted for pregnancy and the partner-treatment workflow runs in parallel. The standard prenatal visit at the first appointment in the U.S. includes gonorrhea testing in most settings.
Why so many women never know they are infected
Roughly half of women with gonorrhea report no symptoms at all in the early weeks. When symptoms do appear, they often look like other, less alarming conditions:
- Mild cervical inflammation is often mistaken for a yeast infection or bacterial vaginosis.
- Slightly heavier or earlier periods can be written off as cycle variation.
- Burning during urination overlaps with a basic UTI.
- Mild abdominal cramping is easy to dismiss as ovulation pain.
The result is that many women are first diagnosed only when a partner tests positive, when they show up for routine STI screening, or, more troublingly, when fertility difficulties prompt an evaluation that finds tubal scarring on imaging.
The CDC's gonorrhea page addresses this gap by recommending annual gonorrhea (and chlamydia) screening for:
- All sexually active women under 25
- Women 25 and older with new or multiple sexual partners
- Anyone whose partner has a recent STI diagnosis
- Pregnant women at the first prenatal visit, and again later in pregnancy if at higher risk
Annual screening at this rate would catch most infections during the early cervical-only phase, before they have time to ascend. The barrier is rarely the test itself; it is access, time, and the stigma some women feel about asking for STI screening even from their primary-care provider.
1 in 8 women with a history of PID experience difficulties getting pregnant. PID is also a common cause of chronic pelvic pain and ectopic pregnancy.
Testing options: what at-home rapid tests can and cannot tell you
Women testing for gonorrhea can choose between three main pathways, each with a different speed-accuracy trade-off:
- Laboratory NAAT (nucleic acid amplification test). The clinical gold standard, performed on a cervical, vaginal, or urine sample. Sensitivity above 95 percent. Run by clinics, requires a visit, results in 1 to 5 days. This is the test of record for confirming infection and guiding treatment.
- At-home rapid lateral-flow swab. A self-collected vaginal swab tested at home using cassette chemistry that detects gonococcal antigens. Reads in about 15 minutes. Useful from roughly 5 to 14 days post-exposure. A positive result is a strong signal to start treatment, ideally confirmed with a clinic NAAT. A negative result after an exposure event is not a definitive all-clear if it is too early in the window.
- Mail-in lab kit. You collect at home, ship to a lab, and receive a NAAT-grade result in 2 to 7 days. Higher analytical sensitivity than rapid lateral-flow but slower.
Rapid at-home tests are best understood as screening tools, not replacements for clinic testing in symptomatic cases. They serve two situations particularly well: regular check-ins between annual clinic visits, and post-exposure screening for the asymptomatic majority who would otherwise put off testing entirely. For symptomatic infections, especially with pelvic pain or fever, a clinic visit is the right step regardless of what an at-home swab shows.
If both you and a current partner test positive, both partners need treatment to prevent ping-pong reinfection. Many clinics offer expedited partner therapy, where a treating clinician prescribes for the partner without requiring a separate visit.
Treatment, partner notification, and preventing reinfection
When gonorrhea is caught early, treatment is straightforward: a single intramuscular dose of ceftriaxone (500 mg for people weighing under 150 kg), the current first-line antibiotic recommended by the CDC treatment guidelines for uncomplicated gonorrhea. If chlamydia co-infection is suspected or confirmed, oral doxycycline is added for one week. Both regimens are highly effective when started promptly.
A few caveats are worth knowing before starting treatment:
- Antibiotic resistance is rising. Strains of N. gonorrhoeae resistant to older antibiotics like azithromycin and ciprofloxacin are widespread, which is why ceftriaxone is now the only recommended single-dose regimen. The CDC monitors resistance closely, and treatment failures should be reported.
- Partner treatment is non-negotiable. Anyone you have had sex with in the 60 days before symptom onset (or diagnosis, if you were asymptomatic) should be tested and treated. Without this, reinfection within weeks is very common.
- Retest after 3 months. The purpose is to catch reinfection, not to verify the cure. The CDC recommends a follow-up test at the 3-month mark regardless of how confident you are in your partner's treatment status.
Prevention going forward rests on a few consistent habits: condom use during vaginal and anal sex, open conversations about testing status before new partnerships, and annual screening if you are under 25 or have new partners.
Azithromycin and ciprofloxacin used to be standard options for gonorrhea. Resistance to both is now too widespread for either to be used as monotherapy in the United States. If a clinician offers a different antibiotic regimen, ask whether it is being given because of an allergy or pregnancy adjustment, not because of cost or availability. A treatment failure with the wrong drug is a worse outcome than waiting an extra day for ceftriaxone.
When to test if you are worried about a specific exposure
The window between exposure and a reliably detectable infection varies by test type. For gonorrhea specifically:
- Rapid antigen swab (at-home). Most reliable from about 5 to 14 days post-exposure. Earlier than 5 days, the bacterial load may be too low to detect. From day 14 onward, the test is at its peak sensitivity.
- Lab NAAT. Detectable as early as 2 to 5 days post-exposure for the most sensitive assays, with peak sensitivity by 1 to 2 weeks. A negative NAAT at 2 weeks post-exposure is highly reassuring.
If your last unprotected exposure was within the last 5 days, you have two reasonable options: wait until day 5 or later before swabbing at home, or visit a clinic right away for a NAAT. If you have symptoms, do not wait; test now and follow up regardless of the result.
One scenario where rapid at-home testing is genuinely the right answer: you are sexually active, have no symptoms, and want a routine check between annual clinic visits. The 15-minute swab is fast, private, and a positive result still leads you to the clinic for treatment. For broader symptoms-and-causes context, the NHS gonorrhoea page is a good patient-facing overview.
| Test type | Earliest reliable window | Peak sensitivity | Best for |
|---|---|---|---|
| At-home rapid swab (lateral flow) | About day 5 post-exposure | Day 14 onward | Private routine screening; quick post-exposure check for asymptomatic women |
| Mail-in lab swab (NAAT) | About day 2 to 5 | About day 7 to 14 | Private testing with lab-grade sensitivity; tolerable 2 to 7 day wait |
| Clinic NAAT | About day 2 to 5 | About day 7 to 14 | Same-week diagnosis when symptoms are present, in pregnancy, or after a known partner exposure |
Frequently Asked Questions
- Can I still have gonorrhea even if I have no symptoms?
- Yes. Roughly half of women with gonorrhea have no early symptoms at all. This is the central reason annual screening is recommended for sexually active women under 25 and for older women with new or multiple partners. The absence of symptoms is not evidence of being infection-free.
- How long after exposure can gonorrhea be detected?
- A rapid at-home antigen swab is most reliable from about 5 to 14 days post-exposure. A laboratory NAAT can detect infection as early as 2 to 5 days, with peak sensitivity by 1 to 2 weeks. If your last possible exposure was less than 5 days ago, wait a few days before testing at home, or visit a clinic for a NAAT now.
- If gonorrhea is treated quickly, will my fertility be unaffected?
- Most likely yes. The CDC considers a single-dose ceftriaxone injection highly effective for uncomplicated gonorrhea infections. Fertility damage almost always reflects an infection that ascended into the fallopian tubes before treatment, rather than the infection itself. The earlier the treatment, the lower the risk.
- Can PID be reversed once it has caused tubal damage?
- Antibiotics can clear the active infection and stop further damage, but scar tissue that has already formed is generally permanent. Surgical procedures like tubal microsurgery can sometimes restore tube function in mild cases, and IVF bypasses tubal damage entirely. Prevention is far more effective than reversal.
- Do I need to tell my partner if I test positive?
- Yes. Partners from the prior 60 days should be notified, tested, and treated. Without partner treatment, reinfection is very likely within weeks. Many U.S. states allow expedited partner therapy, where a clinician can write a prescription for a partner without an additional visit. Some health departments will also notify partners anonymously if you prefer.
- Can men get PID from gonorrhea?
- Men do not develop PID, which is by definition an infection of the upper female reproductive tract. Men can develop epididymitis (infection of the tube behind the testicle), urethritis, and proctitis from untreated gonorrhea, and these conditions can also affect male fertility. Partner treatment is still essential.
- Is the at-home rapid swab accurate enough to rely on?
- Rapid lateral-flow swabs are reliable for screening when used in the right window (5 to 14 days post-exposure). Their sensitivity is high but slightly lower than laboratory NAAT, which remains the clinical gold standard. A positive at-home result should be confirmed at a clinic before or alongside starting treatment. A negative result is reassuring but does not rule out very early infection.
- How often should I get tested if I have multiple partners?
- The CDC recommends at minimum annual screening for sexually active women under 25 and for older women with new or multiple partners. Many clinicians suggest screening every 3 to 6 months with multiple partners or partners of unknown STI status, plus immediate testing after any specific exposure concern.
- U.S. Centers for Disease Control and Prevention. About Gonorrhea: transmission, symptoms in women, screening recommendations, and the most common complications of untreated infection.
- U.S. Centers for Disease Control and Prevention. About Pelvic Inflammatory Disease: fallopian-tube damage, ectopic pregnancy risk, and the 1-in-8 fertility difficulty statistic following PID.
- U.S. Centers for Disease Control and Prevention. STI Treatment Guidelines: recommended single-dose ceftriaxone regimen for uncomplicated gonococcal infection of the cervix, urethra, or rectum.
- World Health Organization. Fact sheet on gonorrhoea (Neisseria gonorrhoeae infection): global burden, complications including ectopic pregnancy and infertility, and antimicrobial resistance trends.
- NHS. Patient guide to pelvic inflammatory disease, including the tiered urgency guidance for symptoms warranting an urgent GP call, NHS 111, or A&E.
- NHS. Patient guide to gonorrhoea: symptoms, complications, treatment, and testing options in the United Kingdom.
